{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Jury Finds Amgen Antibody Patents Not Invalid",
"url": "https://www.lexblog.com/2019/03/18/jury-finds-amgen-antibody-patents-not-invalid/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-MB42JF90",
"url": "https://www.lexblog.com/lib/MB42JF90/"
},
"datePublished": "2019-03-18T19:54:45-04:00",
"dateModified": "2021-11-08T08:21:20-05:00",
"author": {
"@type": "Person",
"name": "Benjamin R. Holt"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Rothwell Figg"
},
"organizationScope": "at-publication",
"isPartOf": "Biosimilars Law Bulletin",
"about": "Intellectual Property",
"sourceUrl": "http://www.biosimilarsip.com/?p=4810",
"sourceStability": "may-move"
}